Author: Reuters

LONDON (Reuters) – Technology stocks rallied on Monday at the start of a big week of earnings for the sector globally, while bond yields hit multi-year highs as investors braced for major central banks to step back from...

PARIS/LONDON (Reuters) – French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying...

SYDNEY (Reuters) – Asian shares extended their bull run on Monday amid upbeat corporate earnings and strong global economic growth, while the dollar struggled to bounce as the White House continued to complain of...

CLARKSVILLE, Tenn. (Reuters) – When President Donald Trump’s imposed steep tariffs on imported washing machines last week it was a “Not Again” moment for officials in this north Tennessee city that has...

CHICAGO (Reuters) – New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi’s Dengvaxia, according to vaccine experts,...